Umlc Bio Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 10.00 K
as on 12-12-2024
- Company Age 1 Year 11 Months
About Umlc Bio Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Chaitanya Pavuluri, Mallikarjuna Pagadala, Pirati Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299TG2023PTC170033
- Company No.
170033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Umlc Bio Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chaitanya Pavuluri  | Director | 04-Jan-2023 | Current |
| Mallikarjuna Pagadala | Director | 04-Jan-2023 | Current |
| Pirati Kumar | Director | 04-Jan-2023 | Current |
| Keshava Pirati | Director | 04-Jan-2023 | Current |
Financial Performance and Corporate Structure Insights of Umlc Bio Pharmaceuticals.
Enhance accessibility to Umlc Bio Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Umlc Bio Pharmaceuticals?
Unlock access to Umlc Bio Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bloomedha Info Solutions Private LimitedActive 14 years 1 monthChaitanya Pavuluri is a mutual person
- Umlc Global Technologies Private LimitedActive 1 month
Mallikarjuna Pagadala and Keshava Pirati are mutual person
- Umlc Global Consultancy Private LimitedActive 4 months 7 days
Mallikarjuna Pagadala and Keshava Pirati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Umlc Bio Pharmaceuticals?
Umlc Bio Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umlc Bio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umlc Bio Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
